Catalog Number 328440 |
Device Problem
Defective Device (2588)
|
Patient Problems
Itching Sensation (1943); Reaction, Injection Site (2442); Skin Inflammation (2443)
|
Event Date 07/23/2019 |
Event Type
malfunction
|
Manufacturer Narrative
|
Device expiration date: unknown.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.
|
|
Event Description
|
It was reported that the syringe 0.3 ml 31ga 8 mm half unit 10bg 500 experienced product damage with the device still considered operable.Product defect was noted after use.The following information was provided by the initial reporter: material no.328440, batch no.Unknown.Verbatim: consumer getting red marks at injection site never seen this before this box--- evaluation results request.Consumer using a new needle with each injection.Wipes site down with alcohol.Diabetic injecting with bd for 39 years.Using syringes with insulin 3 units twice a day.Found in the past few days on her injection site left hip her 8 sites with red marks that itch.This morning 7/23/2019 used her right hip and same happened.Got a red mark.Some other needles feel point damaged.No known allergies to anything or metals.Found after injection.No medical appointments made for this incident at this time.Takes the syringes out of box and bags keeps them in a zip lock bag for traveling use.Always using the same size syringe of bd.Denied reuse.
|
|
Manufacturer Narrative
|
H.6.Investigation: customer returned (11) 3/10cc, 8mm, 31g syringes (1 loose, 10 in a sealed poly bag) from lot#: 8260803.Customer states that after the injection there are red marks that itch and the needle point is damaged.All returned syringes were tested (#1 loose, #2-11 from the sealed poly bag) for point geometry, lube, and cannula od (specs: outer diameter for 31g: 0.0100¿-0.0105¿).All observations fall within specifications.A review of the device history record was completed for batch#: 8260803 all inspections were performed per the applicable operations qc specifications.There were two (2) notifications [200779743, 200779545] noted that did not pertain to the complaint.Root cause cannot be determined at this time as the issue is unconfirmed.H3 other text : see h.10.
|
|
Event Description
|
It was reported that the syringe 0.3ml 31ga 8mm halfunit 10bg 500 experienced product damage with the device still considered operable.Product defect was noted after use.The following information was provided by the initial reporter: material no: 328440, batch no: unknown.Consumer getting red marks at injection site never seen this before this box.Evaluation results request.Consumer using a new needle with each injection.Wipes site down with alcohol.Diabetic injecting with bd for 39 years.Using syringes with insulin 3 units twice a day.Found in the past few days on her injection site left hip her 8 sites with red marks that itch.This morning on (b)(6) 2019 used her right hip and same happened.Got a red mark.Some other needles feel point damaged.No known allergies to anything or metals.Found after injection.No medical appointments made for this incident at this time.Takes the syringes out of box and bags keeps them in a zip lock bag for traveling use.Always using the same size syringe of bd.Denied reuse.
|
|
Search Alerts/Recalls
|